Xbox ANZ and Cure Cancer, partnering with Dr. Arutha Kulasinghe of The University of Queensland, have unveiled three custom Xbox Series X consoles inspired by Dr. Kulasinghe’s award-winning cancer research. The exclusive consoles will be auctioned off, with all proceeds supporting Cure Cancer to continue their remarkable work.
The distinctive design on the consoles draws inspiration from Dr. Kulasinghe’s spatial tumour mapping approach developed in collaboration with Akoya Biosciences and Nanostring Technologies, a process that allows medical experts and specialists to identify cellular architecture and areas of that are resistant to treatment for the first time. The tumour mapping can be life-changing for those who are undergoing cancer treatment.
Dr. Arutha Kulasinghe commented: “These groundbreaking realisations of how cells organise and communicate have been captured by these images that are now featured on the Xbox Series X consoles. With Xbox and Cure Cancer, we’ve been able to further highlight the transformative leaps we’ve achieved in cancer research.”
From today until 30th April, the custom-designed consoles will be on display at the Microsoft Experience Centre at Westfield Sydney, while the auction is running.
Nikki Kinloch, Cure Cancer CEO said: “It is truly incredible how this rare moment of scientific breakthrough is beautifully represented through this collaboration with Xbox. It brings much-needed awareness for supporting groundbreaking cancer research to the wider community, which has always been our mission at Cure Cancer. We are extremely proud of Dr Arutha. Being able to see resistance and sensitivity to current generations of cancer therapies at the time of diagnosis is groundbreaking, and it can be life-changing for those who are going through cancer treatment.”
The auction is live now. For more information, see here. For those looking to support Cure Cancer elsewhere, you can donate with your Microsoft Rewards points and help to bring about real positive change. Head to the Rewards Hub for more details.
